Abstract:The isolated copper(II) complex [CuL(-phen)]·HO () [HL = -HO-CHC(H)=N-CH-SH-, -phen = 1,10-phenanthroline] was structurally characterized using single-crystal X-ray crystallography. in CHCN at liquid nitrogen temperature displayed a characteristic monomeric X-band electron paramagnetic resonance spectrum having a tetragonal character with = 2.1479 and = 2.0691 and ≈ 18.0 mT and ≤ 3.9 mT, respectively. showed a strong binding affinity toward calf thymus DNA as reflected from its intrinsic binding constant ( = 7.88 × 10 M), and its competitive displacement of ethidium bromide suggested an intercalative DNA-binding mode ( = 1.32 × 10 M). This was confirmed from the viscosity study that showed an increase in the viscosity of DNA with an increasing concentration of . Complex is highly efficient in promoting oxidative and hydrolytic DNA cleavage ( = 1.987 h). showed a strong binding affinity with the carrier protein human serum albumin (HSA) ( = 5.22 × 10 M). A high bimolecular quenching constant = 2.29 × 10 Ms indicated a static quenching mechanism involved in the fluorescence quenching of HSA by . Fluorescence resonance energy transfer theory suggested that the distance ( = 3.52 nm) between and HSA is very close. Molecular docking studies suggested that primarily binds to HSA in subdomain IIA. A protein-ligand interaction profiler was used to visualize hydrophobic, hydrogen bonds, and π-cation interactions between HSA and . A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay using HeLa and MDA-MB-231 cells showed a significant in vitro anticancer activity of (IC 2.63 and 2.68 μM, respectively). Nuclear staining assays suggested apoptotic cell death in HeLa cells treated with . The effect of on the cytoskeletal actin filaments visualized using phalloidin staining showed extensive destruction of actin filaments. Flow cytometric analysis indicated that inhibits the growth of HeLa cells through cell cycle arrest in the S phase. Western blot analysis showed upregulation in the expression of apoptotic marker proteins caspase 3, p53, and Bax. These results collectively indicate that induces apoptosis by promoting DNA damage and has a high potential to act as an anticancer agent.

Structural, Vibrational, Thermal, and Cytotoxic Characterization of Aqua(1,10‐Phenanthroline)(L‐Serinato)Copper(II) Nitrate Complex Combined with DFT Calculations

Synthesis, electronic and vibrational properties, solvation effects, ADME and cytotoxic assay of aqua-(1,10-phenanthroline)-tyrosinato-copper(II) nitrate dihydrate complex: experimental and theoretical studies

Bis(3-methylbenzoato-κ2O,O′)(phenanthroline-κ2N,N′)copper(II)

Cellular ultrastructural studies and biological effects of copper complexes of phenanthroline derivatives

Stability studies on 12-(5′-8′- hydroxyquinolinic)methylene-1,4,7,10-tetraazacyclo tridecane-11,13-dione, 5-substituted 1,10-phenanthroline-copper(II) with Cu2+ or Co2+ binuclear mixed-coordinated systems

Studies on stabilities of 6-(5′-8′-hydroxyquinolinic)methylene-1,4,8,11-tetraazacyclo tetradecane-5,7-dione, 5-substituted 1,10-phenanthroline-copper(II) with Cu2+ or Co2+ binuclear mixed-coordinated systems

A Novel Cytotoxic Ternary Copper(ii) Complex of 1,10-Phenanthroline and L-threonine with DNA Nuclease Activity.

Synthesis, Crystal Structure And Antitumor Activity Of Mixed Ligand Coordination Compound Of Copper With Norfloxacin And 1,10-Phen, [Cu(Nflx)(Phen)(H2o)] No3 Center Dot 3h(2)O

Mixed Ligand Mononuclear Copper(II) Complex as a Promising Anticancer Agent: Interaction Studies with DNA/HSA, Molecular Docking, and In Vitro Cytotoxicity Studies.

Synthesis, Characterization, Crystal Structure and Antitumor Activities of a Novel Demethylcantharidato Bridged Copper(ii) Phenanthroline Complex

Synthesis, structural characterization, in vitro biological activity, and DFT calculations of Cu(II) complex

Antitumor copper(II) complexes with hydroxyanthraquinones and N,N-heterocyclic ligands

Solvatomorphic Diversity in Coordination Compounds of Copper(II) with l-Homoserine and 1,10-Phenanthroline: Syntheses, Crystal Structures and ESR Study

Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer

Synthesis, Crystal Structure, Antibacterial And Antitumor Activities Of A New Binuclear Copper(Ii) Complex With 1,10-Phen And Fluoroquinolone

L-Citrullinato-Bipyridine and L-Citrullinato-Phenanthroline Mixed Copper Complexes: Synthesis, Characterization and Potential Anticancer Activity

Synthesis, Crystal Structure, Dna Cleavage Properties, and Protein Binding Activities of an Unsymmetrical Dinuclear Copper( Ii) Complex

Aqua(1,10-phenanthroline)[1,1,1-trifluoro-3-(2-thenoyl)acetonato]copper(II) (1,10-Phenanthroline)(5-sulfonatosalicylato)[1,1,1-trifluoro-3-(2-thenoyl)acetonato]cuprate(ii)

Dichloro-bis(theophylline)-copper(II) complex: Characterization of the physicochemical, computational pharmacokinetics, molecular docking, and cytotoxicity as potential antitumoral medicine

A polymeric copper complex based on a pyrazole derivative: Synthesis, spectroscopic, X‐ray, and biological activity studies

Design, synthesis and structure of a trinuclear copper(II) complex having Cu3OH core with regard to aspects of antiproliferative activity and magnetic properties